Position in LLY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$3,101,726
+$810,579 QoQ
Shares Held
2,586
+3.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#2,096
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Archford Capital Strategies, LLC holds $29,267,302 across 10 Drug Manufacturers - General names. LLY ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,636 | $10,320,324 | |
| 2 | NVS |
Novartis AG
|
49,908 | $7,821,581 | |
| 3 | MRK |
Merck & Co., Inc.
|
27,354 | $3,514,989 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
2,586 | $3,101,726 | |
| 5 | ABBV |
AbbVie Inc.
|
6,013 | $1,513,111 | |
| 6 | SNY |
Sanofi
|
33,227 | $1,417,463 | |
| 7 | AZN |
Astrazeneca PLC
|
2,652 | $502,872 | |
| 8 | PFE |
Pfizer Inc
|
18,376 | $442,494 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,101,726 | 2,586 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,291,147 | 2,491 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,462,092 | 2,291 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,759,478 | 2,306 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,797,596 | 2,306 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,021,001 | 2,447 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,205,344 | 4,152 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $3,618,178 | 4,084 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,667,694 | 4,051 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $3,322,667 | 4,271 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $2,388,223 | 4,097 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,451,461 | 4,564 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,123,541 | 4,528 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,509,674 | 4,396 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,434,458 | 3,921 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,105,533 | 3,419 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,027,484 | 3,169 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $844,791 | 2,950 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $725,077 | 2,625 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $591,950 | 2,562 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $549,700 | 2,395 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $436,598 | 2,337 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,565,991 | 9,275 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,376,586 | 9,300 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $1,547,068 | 9,423 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $1,312,846 | 9,464 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||